5AM Opportunities II (GP), LLC

Holdings History for Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Symbol: ZNTL on Nasdaq
Investment type: Equity / Common Stock,$0.001 par value per share
Latest Disclosed Shares Owned: 4,838,571 shares
Security Ownership %: 6.4%

Andrew J. Schwab ownership in Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL)

30 Dec 2025 - Andrew J. Schwab has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,838,571 shares of Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL). This represents 6.4% ownership of the company. This is the first filing by 5AM Opportunities II (GP), LLC disclosing ownership of Zentalis Pharmaceuticals, Inc. Common Stock,$0.001 par value per share (ZNTL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Andrew J. Schwab	6.4%		$7,257,856	4,838,571			$1.50	13G	18 Dec 2025	30 Dec 2025, 16:10